AllPennyStocks.com Micro Cap Company Is Soaring On Phase 2 Trial Update

Micro Cap Company Is Soaring On Phase 2 Trial Update

Micro Cap Company Is Soaring On Phase 2 Trial Update By: Dylan Sikes – AllPennyStocks.com News

Tuesday, October 29, 2024

Pharma and biotech stocks seem to be stealing the show as of late, and this certain Maryland-based pharma company is no exception on Tuesday. A certain micro cap is soaring after it was announced that it has successfully dosed the first three patients with its ropidoxuridine drug candidate in a phase 2 trial of the prospective radiation sensitizer in patients with glioblastoma.

Traders were quick to snatch up shares of Shuttle Pharmaceuticals Holdings Inc. (Nasdaq:SHPH) following the announcement, with the price being pushed up to $2.25/share (+69.17%) at the early session high. This move could be an indication of things to come as it appears that the stock could be breaking out of a multi-month downtrend following this announcement. 

Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.


Copyright © 2024 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Quebec Awards $18 Million to Support Production of Lithium Iron Batteries
Firm Using AI to Transform Clinical Trials Sees Share Price Gain
Crypto Miner Sees 413% Revenue Growth On Strong Bitcoin Mining Operations
Most Popular


Back to Top